Related Experiment Video

Updated: May 20, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells

Haojian Zhang1, Cong Peng, Yiguo Hu

  • 1Department of Medicine, Division of Hematology/Oncology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Nature Genetics
|July 17, 2012
PubMed

Insights

Targeting cancer stem cells (CSCs) is a promising therapy. Researchers found that Blk gene acts as a tumor suppressor in leukemic stem cells (LSCs), offering a selective therapeutic strategy for chronic myeloid leukemia (CML).

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Molecular Biology

Background:

  • Targeting cancer stem cells (CSCs) is crucial for effective cancer therapy.
  • Identifying molecular pathways selectively regulating CSC function is key.
  • Chronic myeloid leukemia (CML) serves as a model for studying CSCs.

Purpose of the Study:

  • To investigate the role of the Blk gene in regulating leukemic stem cells (LSCs) in CML.
  • To identify molecular targets for selective eradication of LSCs.
  • To explore the therapeutic potential of modulating the Blk pathway in CML.

Main Methods:

  • Utilized a BCR-ABL-induced CML mouse model.
  • Investigated gene regulation by BCR-ABL and c-Myc in LSCs.
  • Analyzed the function of the Blk gene and its pathway involving Pax5 and p27.
  • Assessed the impact of Blk pathway modulation on CML development and LSC proliferation.
  • Evaluated Blk's effect on human CML stem cells.

Main Results:

  • BCR-ABL downregulates the Blk gene in LSCs via c-Myc.
  • Blk functions as a tumor suppressor in LSCs but not in normal hematopoietic stem cells (HSCs).
  • The Blk pathway, involving Pax5 and p27, suppresses LSC function.
  • Inhibition of the Blk pathway accelerates CML progression.
  • Activation of the Blk pathway delays CML development and suppresses human CML stem cell proliferation.

Conclusions:

  • The Blk pathway is a critical regulator of LSC function in CML.
  • Blk acts as a selective tumor suppressor for LSCs.
  • Targeting the Blk pathway offers a feasible strategy for selective LSC eradication in CML.
  • This approach may be applicable to other cancer types.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...